CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash and cash equivalents	$ 42,229	$ 29,487
Available for sale securities	753	3
Trade accounts and grants receivable, net	1,078	1,042
Inventory	1	266
Landlord receivable	567	378
Prepaid expenses and other current assets	2,609	1,229
Total current assets	47,237	32,405
Equipment, net and construction in progress	7,539	2,858
Deferred license fees	322	337
Deposits and other long-term assets	1,299	453
Equity method investment	4,671	0
Intangible assets, net	33,592	38,848
TOTAL ASSETS	94,660	74,901
CURRENT LIABILITIES
Accounts payable and accrued liabilities	9,377	6,803
Capital lease liability, current portion	38	58
Promissory notes, current portion	95	0
Deferred grant income	2,513	0
Deferred license and subscription revenue, current portion	439	208
Total current liabilities	12,462	7,069
LONG-TERM LIABILITIES
Deferred tax liabilities, net	0	4,515
Deferred revenues, net of current portion	615	0
Deferred rent liabilities, net of current portion	158	97
Lease liability	4,400	378
Capital lease liability, net of current portion	26	31
Related party convertible debt, net of discount	324	60
Promissory notes, net of current portion	220	0
Other long term liabilities	8	28
Total long-term liabilities	$ 5,751	$ 5,109
Commitments and contingencies (Note 8)
SHAREHOLDERS' EQUITY
Series A convertible preferred stock, no par value, authorized 2,000 shares as of December 31, 2015 and 2014; none and 70 issued and outstanding as of December 31, 2015 and 2014, respectively	$ 0	$ 3,500
Common stock, no par value, authorized 125,000 shares; issued and outstanding shares; 94,894 issued and 90,421 outstanding as of December 31, 2015 and 83,122 issued and 78,228 outstanding as of December 31, 2014	274,342	234,850
Accumulated other comprehensive (loss)/income	(237)	186
Accumulated deficit	(229,181)	(182,190)
Treasury stock at cost: 4,473 and 4,894 shares at December 31, 2015 and 2014, respectively	(18,033)	(19,890)
BioTime, Inc. shareholders' equity	26,891	36,456
Non-controlling interest	49,556	26,267
Total shareholders' equity	76,447	62,723
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 94,660	$ 74,901